|
GANC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.139000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.645200E-01 |
| Normal-vs-Stage2 |
1.126810E-01 |
| Normal-vs-Stage3 |
1.870810E-01 |
| Normal-vs-Stage4 |
4.394200E-02 |
| Stage1-vs-Stage2 |
3.251600E-01 |
| Stage1-vs-Stage3 |
3.771900E-02 |
| Stage1-vs-Stage4 |
6.250300E-02 |
| Stage2-vs-Stage3 |
2.074100E-02 |
| Stage2-vs-Stage4 |
1.688100E-02 |
| Stage3-vs-Stage4 |
6.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.494360E-01 |
| Normal-vs-AfricanAmerican |
9.539000E-01 |
| Normal-vs-Asian |
3.238800E-01 |
| Caucasian-vs-AfricanAmerican |
2.387000E-01 |
| Caucasian-vs-Asian |
2.933400E-01 |
| AfricanAmerican-vs-Asian |
4.939200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.787600E-01 |
| Normal-vs-Female |
2.157000E-01 |
| Male-vs-Female |
7.140800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.403400E-01 |
| Normal-vs-Extreme_Weight |
7.180400E-01 |
| Normal-vs-Obese |
3.573600E-01 |
| Normal-vs-Extreme_Obese |
6.873200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.198400E-01 |
| Normal_Weight-vs-Obese |
5.493200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.688200E-01 |
| Extreme_Weight-vs-Obese |
5.528400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.040000E-01 |
| Obese-vs-Extreme_Obese |
9.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.737400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.260400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.691200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.372000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.833800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.438400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.731400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.672300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.126570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.761400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.621610E-02 |
| Normal-VS-Type2 PRCC |
3.524200E-02 |
| Normal-VS-KIRP CIMP |
1.905570E-01 |
| Normal-VS-Unclassified PRCC |
4.041600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.56369999995787E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.860300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.269200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.576000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.218680E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.064300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.167600E-01 |
| Normal-vs-N1 |
5.838000E-03 |
| Normal-vs-N2 |
2.779200E-01 |
| N0-vs-N1 |
2.056500E-02 |
| N0-vs-N2 |
4.672200E-01 |
| N1-vs-N2 |
6.690600E-01 |
|
|
